United States
Securities and Exchange Commission
Washington, D.C. 20549
FORM 10-Q
☒
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended December 31, 2022
or
☐
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Transition Period From _________ to ________
Commission File Number: 1-12235
TRIUMPH GROUP, INC.
(Exact name of registrant as specified in its charter)
Delaware
51-0347963
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
899 Cassatt Road, Suite 210, Berwyn, PA
19312
(Address of principal executive offices)
(Zip Code)
(610) 251-1000
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $.001 per share
TGI
New York Stock Exchange
Purchase Rights
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Securities Exchange Act of 1934. (Check one)
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
The number of outstanding shares of the Registrant's Common Stock, par value $.001 per share, on January 30, 2023, was 65,010,631.
Table of Contents
TABLE OF CONTENTS
Page
Number
Part I. Financial Information
Item 1.
Financial Statements (Unaudited)
Condensed Consolidated Balance Sheets at December 31, 2022 and March 31, 2022
1
Condensed Consolidated Statements of Operations - Three and nine months ended December 31, 2022 and 2021
2
Condensed Consolidated Statements of Comprehensive Income - Three and nine months ended December 31, 2022 and 2021
3
Condensed Consolidated Statements of Stockholders' Deficit - Three and nine months ended December 31, 2022 and 2021
4
Condensed Consolidated Statements of Cash Flows - Nine months ended December 31, 2022 and 2021
6
Notes to Condensed Consolidated Financial Statements - December 31, 2022
7
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
25
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
39
Item 4.
Controls and Procedures
Part II. Other Information
40
Legal Proceedings
Item 1A.
Risk Factors
Unregistered Sales of Equity Securities and Use of Proceeds
Defaults Upon Senior Securities
Mine Safety Disclosures
Item 5.
Other Information
Item 6.
Exhibits
Signatures
42
Condensed Consolidated Balance Sheets
(unaudited)
(Dollars in thousands, except per share data)
December 31,
March 31,
2022
ASSETS
Current assets:
Cash and cash equivalents
$
116,409
240,878
Trade and other receivables, less allowance for credit losses of $7,564 and $7,940
179,371
178,663
Contract assets
108,646
101,828
Inventory, net
400,467
361,692
Prepaid expenses and other current assets
18,449
19,903
Assets held for sale
—
60,104
Total current assets
823,342
963,068
Property and equipment, net
162,278
169,050
Goodwill
507,714
513,722
Intangible assets, net
76,503
84,850
Other, net
27,455
30,476
Total assets
1,597,292
1,761,166
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Current portion of long-term debt
3,108
3,268
Accounts payable
166,501
161,534
Contract liabilities
40,492
171,763
Accrued expenses
160,014
208,059
Liabilities related to assets held for sale
57,519
Total current liabilities
370,115
602,143
Long-term debt, less current portion
1,605,069
1,586,222
Accrued pension and other postretirement benefits
259,671
301,303
Deferred income taxes
7,444
7,213
Other noncurrent liabilities
43,056
51,708
Stockholders' deficit:
Common stock, $.001 par value, 100,000,000 shares authorized, 64,995,466 and 64,629,279 shares issued; 64,995,466 and 64,614,382 shares outstanding
65
64
Capital in excess of par value
957,093
973,112
Treasury stock, at cost, 0 and 14,897 shares
(96
)
Accumulated other comprehensive loss
(455,208
(463,354
Accumulated deficit
(1,190,013
(1,297,149
Total stockholders' deficit
(688,063
(787,423
Total liabilities and stockholders' deficit
See accompanying notes to condensed consolidated financial statements.
Condensed Consolidated Statements of Operations
Three Months Ended December 31,
Nine Months Ended December 31,
2021
Net sales
328,855
319,249
985,839
1,073,291
Operating costs and expenses:
Cost of sales (exclusive of depreciation shown separately below)
240,201
232,328
720,663
788,341
Selling, general and administrative
44,269
42,416
156,432
152,775
Depreciation and amortization
8,624
11,659
27,115
40,035
Restructuring
4,649
2,851
13,031
Loss (gain) on sale of assets and businesses
720
(103,163
13,629
293,814
291,052
803,898
1,007,811
Operating income
35,041
28,197
181,941
65,480
Non-service defined benefit income
(8,576
(14,400
(25,725
(23,127
Debt extinguishment loss
1,441
1,935
11,624
Warrant remeasurement gain, net
(5,537
Interest expense and other, net
36,361
32,319
100,726
105,060
Income (loss) from continuing operations before income taxes
11,352
8,343
111,036
(28,077
Income tax expense
400
1,105
3,900
4,106
Net income (loss)
10,952
7,238
107,136
(32,183
Earnings (loss) per share—basic:
0.17
0.11
1.65
(0.50
Weighted average common shares outstanding—basic
65,066
64,621
64,969
64,486
Earnings (loss) per share—diluted:
0.08
1.53
Weighted average common shares outstanding—diluted
68,454
65,096
66,346
Condensed Consolidated Statements of Comprehensive Income
(Dollars in thousands)
Other comprehensive income:
Foreign currency translation adjustment
14,050
(776
(8,765
(3,719
Defined benefit pension plans and other postretirement benefits:
Amounts arising during the period - net of tax expense
Actuarial gain, net of taxes of $0, $0, $0, and $0, respectively
10,440
Reclassification to net income (loss) - net of expense
Amortization of net loss, net of taxes of $0, $0, $0, and $0, respectively
6,574
8,514
19,722
25,525
Recognized prior service (credits) cost, net of taxes of $0, $0, $0, and $0, respectively
(1,251
(1,250
(3,752
3,134
Total defined benefit pension plans and other postretirement benefits, net of taxes
5,323
7,264
15,970
39,099
Cash flow hedges:
Unrealized gain (loss) arising during the period, net of tax expense of $0, $0, $0, and $0, respectively
2,374
662
2,110
(2,670
Reclassification of (loss) gain included in net earnings, net of tax expense of $0, $0, $0, and $0, respectively
(222
(251
(1,169
1,176
Net unrealized gain (loss) on cash flow hedges, net of tax
2,152
411
941
(1,494
Total other comprehensive income
21,525
6,899
8,146
33,886
Total comprehensive income
32,477
14,137
115,282
1,703
Condensed Consolidated Statements of Stockholders' Deficit
For the three and nine months ended December 31, 2022
OutstandingShares
CommonStockAll Classes
Capital inExcess ofPar Value
TreasuryStock
AccumulatedOtherComprehensiveLoss
AccumulatedDeficit
Total
March 31, 2022
64,614,382
Net loss
(10,342
(10,382
Pension liability adjustment, net of income taxes of $0
Change in fair value of foreign currency hedges, net of income taxes of $0
(838
Share-based compensation
471,676
1,656
1,657
Repurchase of shares for share-based compensation minimum tax obligation
(172,282
(3,442
Retirement of treasury shares
(3,538
3,538
Employee stock purchase plan
6,605
160
June 30, 2022
64,920,381
971,390
(469,251
(1,307,491
(805,287
Net income
106,526
(12,433
5,324
(373
51,426
3,970
(4,022
(48
48
12,698
170
September 30, 2022
64,980,483
975,530
(476,733
(1,200,965
(702,103
Issuance of warrants on common shares
(19,500
890
14,983
173
December 31, 2022
64,995,466
For the three and nine months ended December 31, 2021
March 31, 2021
64,185,001
$64
$978,272
$(12,606)
$(530,192)
$(1,254,391)
$(818,853)
(30,351)
2,749
20,629
(706)
355,821
(11,505)
13,975
2,470
(116,796)
(2,336)
9,794
(235)
407
172
June 30, 2021
64,433,820
$966,532
$(560)
$(507,520)
$(1,284,742)
$(826,226)
(9,070)
(5,692)
11,206
(1,199)
196,674
1,480
1,256
2,737
(36,824)
(782)
7,683
78
79
157
September 30, 2021
64,601,353
$65
$968,090
$(7)
$(503,205)
$(1,293,812)
$(828,869)
(776)
2,537
2,544
(855)
(17)
9,985
167
December 31, 2021
64,613,232
$970,787
$(10)
$(496,306)
$(1,286,574)
$(812,038)
5
Condensed Consolidated Statements of Cash Flows
Operating Activities
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of acquired contract liability
(1,832
(3,645
(Gain) loss on sale of assets and businesses
Curtailments, settlements, and special termination benefits loss, net
20,046
Other amortization included in interest expense
4,857
7,502
Provision for credit losses
495
247
Warrants remeasurement gain
(6,435
6,420
7,664
Changes in other assets and liabilities, excluding the effects of acquisitions and divestitures:
Trade and other receivables
(8,579
30,060
(14,667
(7,538
Inventories
(39,829
(5,165
839
3,716
Accounts payable, accrued expenses, and contract liabilities
(63,014
(201,476
(25,647
(42,195
4,013
(678
Net cash used in operating activities
(112,291
(169,981
Investing Activities
Capital expenditures
(12,274
(15,817
(Payments on) proceeds from sale of assets and businesses
(6,160
220,550
Investment in joint venture
(2,101
Purchase of facility related to divested businesses
(21,550
Net cash (used in) provided by investing activities
(18,434
181,082
Financing Activities
Proceeds from issuance of long-term debt
35,000
107
Retirement of debt and finance lease obligations
(21,877
(379,021
Payment of deferred financing costs
(400
Premium on redemption of First Lien Notes
(1,287
(9,108
(3,490
(3,135
Net cash provided by (used in) financing activities
8,346
(391,557
Effect of exchange rate changes on cash
(2,090
(3,287
Net change in cash and cash equivalents
(124,469
(383,743
Cash and cash equivalents at beginning of period
589,882
Cash and cash equivalents at end of period
206,139
Triumph Group, Inc.
Notes to Condensed Consolidated Financial Statements
1. BACKGROUND AND BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements of Triumph Group, Inc. ("Triumph") have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, the interim financial information includes all adjustments of a normal recurring nature necessary for a fair presentation of the results of operations, financial position, and cash flows. The results of operations for the three and nine months ended December 31, 2022 and 2021, are not necessarily indicative of results that may be expected for the year ending March 31, 2023. The accompanying condensed consolidated financial statements are unaudited and should be read in conjunction with the fiscal 2022 audited consolidated financial statements and notes thereto included in the Company's Form 10-K for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission (the "SEC") on May 23, 2022.
Triumph is a Delaware corporation that, through its operating subsidiaries, designs, engineers, manufactures, and sells products for global aerospace original equipment manufacturers ("OEMs") of aircraft and aircraft components and repairs and overhauls aircraft components and accessories for commercial airline, air cargo carrier, and military customers on a worldwide basis. Triumph and its subsidiaries (collectively, the "Company") are organized based on the products and services that they provide. The Company has two reportable segments: Systems & Support and Aerospace Structures.
Systems & Support consists of the Company’s operations that provide integrated solutions, including design; development; and support of proprietary components, subsystems and systems, as well as production of complex assemblies using external designs. Capabilities include hydraulic, mechanical and electromechanical actuation, power and control; a complete suite of aerospace gearbox solutions, including engine accessory gearboxes and helicopter transmissions; active and passive heat exchange technology; fuel pumps, fuel metering units, and Full Authority Digital Electronic Control fuel systems; and hydromechanical and electromechanical primary and secondary flight controls. Systems & Support also provides full life cycle solutions for commercial, regional, and military aircraft. The Company’s extensive product and service offerings include full post-delivery value chain services that simplify the maintenance, repair, and overhaul (“MRO”) supply chain. Through its ground support equipment maintenance, component MRO, and post-production supply chain activities, Systems & Support is positioned to provide integrated planeside repair solutions globally. Capabilities include repair services for metallic and composite aircraft structures; nacelles; thrust reversers; interiors; auxiliary power units; and a wide variety of pneumatic, hydraulic, fuel, and mechanical accessories. Repair services generally involve the replacement and/or remanufacturing of parts, which is similar to the original manufacture of the part. The processes that the Company performs related to repair and overhaul services are essentially the repair of wear parts or the replacement of parts that are beyond economic repair. The repair service generally involves remanufacturing a complete part or a component of a part.
Aerospace Structures consists of the Company’s operations that supply commercial, business, and regional manufacturers with large metallic and composite structures and aircraft interior systems, including air ducting and thermal acoustic insulations systems. Products include wings; wing boxes; fuselage panels; horizontal and vertical tails; subassemblies such as floor grids; and aircraft interior systems, including air ducting and thermal acoustic insulation systems. Aerospace Structures also has the capability to engineer detailed structural designs in metal and composites. Capabilities include advanced composite and interior structures, joining processes such as welding, and conventional mechanical fasteners. Subsequent to the divestitures disclosed in Note 3, the remaining operations of Aerospace Structures are those that supply commercial and regional manufacturers with aircraft interior systems.
The accompanying condensed consolidated financial statements include the accounts of Triumph and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated from the accompanying condensed consolidated financial statements.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Use of Estimates
The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Revenue Recognition and Contract Balances
The Company's revenue is principally from contracts with customers to provide design, development, manufacturing, and support services associated with specific customer programs. The Company regularly enters into long-term master supply agreements that establish general terms and conditions and may define specific program requirements. Many agreements include clauses that provide sole supplier status to the Company for the duration of the program’s life. Purchase orders (or authorizations to proceed) are issued pursuant to the master supply agreements. Additionally, a majority of the Company’s agreements with customers include options for future purchases. Such options primarily reduce the administrative effort of issuing subsequent purchase orders and do not represent material rights granted to customers. The Company generally enters into agreements directly with its customers and is the principal in all current contracts.
The identification of a contract with a customer for purposes of accounting and financial reporting requires an evaluation of the terms and conditions of agreements to determine whether presently enforceable rights and obligations exist. Management considers a number of factors when making this evaluation that include, but are not limited to, the nature and substance of the business exchange, the specific contractual terms and conditions, the promised products and services, the termination provisions in the contract, as well as the nature and execution of the customer’s ordering process and how the Company is authorized to perform work. Generally, presently enforceable rights and obligations are not created until a purchase order is issued by a customer for a specified number of units of product or services. Therefore, the issuance of a purchase order is generally the point at which a contract is identified for accounting and financial reporting purposes.
Management identifies the promises to the customer. Promises are generally explicitly stated in each contract, but management also evaluates whether any promises are implied based on the terms of the agreement, past business practice, or other facts and circumstances. Each promise is evaluated to determine if it is a performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service. The Company considers a number of factors when determining whether a promise is a distinct performance obligation, including whether the customer can benefit from the good or service on its own or together with other resources that are readily available to the customer, whether the Company provides a significant service of integrating goods or services to deliver a combined output to the customer, or whether the goods or services are highly interdependent. The Company’s performance obligations consist of a wide range of engineering design services and manufactured components, as well as spare parts and repairs for OEMs.
The transaction price for a contract reflects the consideration the Company expects to receive for fully satisfying the performance obligations in the contract. Typically, the transaction price consists solely of fixed consideration but may include variable consideration for contractual provisions such as unpriced contract modifications, cost-sharing provisions, and other receipts or payments to customers. The Company identifies and estimates variable consideration, typically at the most likely amount the Company expects to receive from its customers. Variable consideration is only included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for the contract will not occur, or when the uncertainty associated with the variable consideration is resolved. Consideration paid or payable to a customer is reflected as a reduction in net revenues when the amounts paid are not related to a distinct good or service at the later of when the related revenue is recognized or when the Company pays or promises to pay the consideration to the customer. The Company's contracts with customers generally require payment under normal commercial terms after delivery with payment typically required within 30 to 120 days of delivery.
The Company generally is not subject to collecting sales tax and has made an accounting policy election to exclude from the transaction price any sales and other similar taxes collected from customers. As a result, any such collections are accounted for on a net basis.
The total transaction price is allocated to each of the identified performance obligations using the relative stand-alone selling price. The objective of the allocation is to reflect the consideration that the Company expects to receive in exchange for the products or services associated with each performance obligation. Stand-alone selling price is the price at which the Company would sell a promised good or service separately to a customer. Stand-alone selling prices are established at contract inception, and subsequent changes in transaction price are allocated on the same basis as at contract inception. When stand-alone selling prices for the Company’s products and services are not observable, the Company uses either the “Expected Cost Plus a Margin” or "Adjusted Market Assessment" approaches to estimate stand-alone selling price. Expected costs are typically derived from the available periodic forecast information.
Revenue is recognized when or as control of promised products or services transfers to a customer and is recognized at the amount allocated to each performance obligation associated with the transferred products or services. Service sales, principally representing repair, maintenance, and engineering activities are recognized over the contractual period or as services are rendered. Sales under long-term contracts with performance obligations satisfied over time are recognized using either an input or output method. The Company recognizes revenue over time as it performs on these contracts because of the continuous transfer of control to the customer as represented by contractual terms that entitle the Company to the reimbursement of costs plus a
8
reasonable profit for work performed to manufacture products for which the Company has no alternate use or for work performed on a customer-owned asset.
With control transferring over time, revenue is recognized based on the extent of progress toward completion of the performance obligation. The Company generally uses the cost-to-cost input method of progress for its contracts because it best depicts the transfer of control to the customer that occurs as work progresses. Under the cost-to-cost method, the extent of progress toward completion is measured based on the proportion of costs incurred to date to the total estimated costs at completion of the performance obligation. The Company reviews its cost estimates on contracts on a periodic basis, or when circumstances change and warrant a modification to a previous estimate. Cost estimates are largely based on negotiated or estimated purchase contract terms, historical performance trends, and other economic projections. Significant factors that influence these estimates include inflationary trends, technical and schedule risk, internal and subcontractor performance trends, business volume assumptions, asset utilization, and anticipated labor agreements.
Revenue and cost estimates are regularly monitored and revised based on changes in circumstances. Impacts from changes in estimates of net sales and cost of sales are recognized on a cumulative catch-up basis, which recognizes in the current period the cumulative effect of the changes on current and prior periods based on a performance obligation’s percentage of completion. Forward loss reserves for anticipated losses on long-term contracts are recorded in full when such losses become evident, to the extent required, and are included in contract liabilities on the accompanying condensed consolidated balance sheets. The Company believes that the accounting estimates and assumptions made by management are appropriate given the increased uncertainties surrounding the severity and duration of the impacts of the COVID-19 pandemic; however, actual results could differ materially from those estimates.
For the three months ended December 31, 2022, cumulative catch-up adjustments resulting from changes in contract values and estimated costs that arose during the fiscal year increased net sales, operating income, net income, and earnings per diluted share by approximately $1,459, $748, $748, and $0.01, respectively. For the three months ended December 31, 2021, cumulative catch-up adjustments resulting from changes in estimates decreased revenue by approximately ($1,791) and increased operating loss, net loss, and loss per share by approximately ($4,599), ($4,599), and ($0.07), respectively.
For the nine months ended December 31, 2022, cumulative catch-up adjustments resulting from changes in contract values and estimated costs that arose during the fiscal year increased net sales, operating income, net income, and earnings per diluted share by approximately $13,360, $20,151, $20,151, and $0.30, respectively. For the nine months ended December 31, 2021, cumulative catch-up adjustments resulting from changes in estimates increased revenue by approximately $5,340, and decreased operating loss, net loss, and loss per share by approximately $13,115, $13,115, and $0.20, respectively.
Revenues for performance obligations that are not recognized over time are recognized at the point in time when control transfers to the customer. For performance obligations that are satisfied at a point in time, the Company evaluates the point in time when the customer can direct the use of and obtain the benefits from the products and services. Generally, the shipping terms determine the point in time when control transfers to customers. Shipping and handling activities are not considered performance obligations and related costs are included in cost of sales as incurred.
Differences in the timing of revenue recognition and contractual billing and payment terms result in the recognition contract assets and liabilities. Refer to Note 4 for further discussion.
Concentration of Credit Risk
The Company’s trade and other accounts receivable are exposed to credit risk. However, the risk is limited due to the diversity of the customer base and the customer base’s wide geographical area. Trade accounts receivable from The Boeing Company ("Boeing") (representing commercial, military, and space) represented approximately 15% and 17% of total trade accounts receivable as of December 31, 2022 and March 31, 2022, respectively. Trade and other accounts receivable from Daher Aerospace Inc. ("Daher") include receivables that largely correspond with payables associated with transition services and represented approximately 17% as of December 31, 2022. Trade and other accounts receivable from Daher were not significant as of March 31, 2022. The Company had no other concentrations of credit risk of more than 10%.
Sales to Boeing for the nine months ended December 31, 2022, were $265,817, or 27% of net sales, of which $137,356 and $128,460 were from Systems & Support and Aerospace Structures, respectively. Sales to Boeing for the nine months ended December 31, 2021, were $376,413, or 35% of net sales, of which $121,057 and $255,357 were from Systems & Support and Aerospace Structures, respectively.
No other single customer accounted for more than 10% of the Company’s net sales. However, the loss of any significant customer, including Boeing, could have a material adverse effect on the Company and its operating subsidiaries.
9
Warrants
On December 1, 2022, the Company’s board of directors declared a distribution to holders of the Company’s shares of common stock in the form of warrants to purchase shares of common stock (the “Warrants”). Holders of common stock received three Warrants for every ten shares of common stock held as of December 12, 2022 (the "Record Date") (rounded down for any fractional warrant). The Company issued approximately 19.5 million Warrants on December 19, 2022, to holders of record of common stock as of the close of business on the Record Date. The Warrants trade on the over-the-counter market.
Each Warrant represents the right to purchase initially one share of common stock, subject to certain anti-dilution adjustments (“Warrant Shares Per Warrant”), at an exercise price of $12.35 per Warrant (the “Exercise Price”), subject to certain anti-dilution adjustments (the “Implied Per Share Exercise Price”). Payment for shares of common stock on exercise of Warrants may be in (i) cash or (ii) under certain circumstances, Designated Notes (as defined below). In the event Designated Notes are used to pay for the exercise of the Warrants, accrued interest (in addition to the stated aggregate principal amount) will be forfeited upon exercise, unless exercise occurs after a record date for the payment of interest and before the resulting scheduled payment date (in which case note holders will receive the scheduled interest payment). If all Warrants were exercised and settled as of December 31, 2022, the Company would be required to issue approximately 19.5 million shares (assuming no over-exercise options, as described below, were exercised). The closing price of the Company’s shares of common stock was $10.52 as of December 31, 2022.
“Designated Notes” means, collectively, any of the issued and outstanding notes of the Company as designated or undesignated by the Company from time to time; provided that any designation by the Company of a particular series of notes as “Designated Notes” shall retain such designation for a minimum of 20 consecutive business days from (and including) the date of publication of notice of the same by press release. The Company also has the right, but not obligation, to remove one or more series of its notes from being “Designated Notes,” but such redesignation shall only be effective 20 consecutive business days from (and including) the date of publication of notice of the same by press release. The Company initially designated the following notes as “Designated Notes,” each as defined in Note 6: the First Lien Notes, the 2024 Notes, and the 2025 Notes.
Pursuant to the terms of the Warrant Agreement, a holder may elect to pay an additional amount equal to $1.8525 (being 0.15 multiplied by the Exercise Price) in exchange for an additional number of shares of common stock equal to the product of 0.15 and the Warrant Shares Per Warrant applicable to the relevant exercise on the terms specified in the Warrant Agreement. If all Warrants were exercised and each holder were to elect to pay the additional $1.8525 to receive additional shares, the Company would be required to issue an additional approximately 2.9 million shares in settlement of the incremental exercise price received.
The Warrants expire on December 19, 2023, subject to (i) the right of the Company to redeem the Warrants on not less than 20 calendar days’ notice (any such date of redemption, the “Redemption Date” and any such date of notice a “Redemption Notice”) at a price of 1/10 of $0.01 per Warrant and (ii) the automatic acceleration of the Expiration Date following the Price Condition Date, as defined and described below.
Unless the Company has previously issued a Redemption Notice with respect to the Warrants, then following the last day of the first 30 consecutive trading day period to occur in which daily volume weighted average prices of the shares of Common Stock has been at least equal to the then applicable Implied Per Share Exercise Price on each of 20 trading days (whether or not consecutive) (the “Price Condition”), the Expiration Date will automatically accelerate to the date that is the 5th business day following the Price Condition Date; provided that the Company may, at its sole option, elect a later Expiration Date by providing public notice no later than the Price Condition Date. The “Price Condition Date” is the first business day following the last Trading Day of the period in which the Price Condition is met.
Any holder that exercises any Warrants from and after (a) 5:00 p.m. New York city time on the earlier of (x) a Price Condition Date and (y) the date that the Company issues a Redemption Notice until (b) 5:00 p.m. New York City time on, as applicable, (x) the Expiration Date and (y) the business day immediately preceding the Redemption Date (the last day of such period, the “Over-Subscription Deadline”), may, subject to the terms of the Warrant Agreement, elect to subscribe for any or all of the shares of Common Stock issuable pursuant to any outstanding but unexercised Warrants as of the Over-Subscription Deadline (the “Over-Subscription Privilege”). To exercise the Over-Subscription Privilege, a holder must deliver an amount in cash equal to the elected over-subscription shares multiplied by the then applicable Implied Per Share Exercise Price (such amount, the “Elected Over-Subscription Shares Amount”) at the same time as the basic warrant exercise right is exercised. Any excess payments received will be returned, without interest, promptly following the settlement date.
An ownership limitation is in place such that a holder of Warrants is not permitted to exercise Warrants for any shares of common stock if following such exercise the holder will have beneficial ownership of common stock in excess of 4.9% of the then issued and outstanding common stock (excluding shares held by subsidiaries); provided, that a holder of Common Stock in excess of 4.9% of the issued and outstanding common stock as of 5:00 p.m. New York City time on December 1, 2022 will be entitled to exercise Warrants received in the Warrant Distribution, but only to the extent such holder’s receipt of such common stock is
10
permitted by a waiver in effect at such time that constitutes “Prior Approval of the Company” under the Tax Benefit Preservation Plan, dated March 11, 2022, between the Company and Computershare Trust Company, N.A., as rights agent.
The Exercise Price and the number of shares of common stock issuable upon exercise are subject to certain anti-dilution adjustments, including for share dividends, splits, subdivisions, spin-offs, consolidations, reclassifications, combinations, noncash distributions, and cash dividends.
The common stock warrants are accounted for as derivative liabilities in accordance with ASC 815-40 and included within accrued liabilities on the accompanying condensed consolidated balance sheets. The Company measured the Warrants at fair value as of the issuance date using a Monte Carlo pricing model, a Level 3 fair value measurement (as described below), due to the level of market activity. Inherent in the option pricing simulation are assumptions related to expected stock-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of the Warrants based on implied and historical volatility of the Company’s common stock. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the Warrants. The expected life of the Warrants is based on the Company’s ability to redeem the Warrants, subject to a 20 calendar-day notice period, as well as the automatic acceleration of the Expiration Date following the Price Condition Date. During the three months ended December 31, 2022, due to increased trading volume, the Company began remeasuring outstanding Warrants using the Warrants trading price, a Level 1 fair value measurement (as described below). The Warrants are remeasured at each balance sheet date. Warrants remeasurement adjustments are recognized in warrants remeasurement gain, net on the accompanying condensed consolidated statements of operations.
At distribution, the fair value of the Warrants was $19,500. At December 31, 2022, the fair value of the Warrants was approximately $13,065 and $6,435 of warrants remeasurement gain has been recognized in the three months ended December 31, 2022. No warrants were exercised following the issuance on December 19, 2022, through December 31, 2022.
Fair Value Measurements
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. When determining fair value measurements for assets and liabilities required to be recorded or disclosed at fair value, the Company considers the principal or most advantageous market in which it would transact and also considers assumptions that market participants would use when pricing an asset or liability. The fair value hierarchy has three levels of inputs that may be used to measure fair value: Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities; Level 2—Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and Level 3—Unobservable inputs for the asset or liability. The Company has applied fair value measurements when measuring the warrants (see above), comparing the carrying value of assets held for sale with the related fair value less cost to sell (see Note 3), when disclosing the fair value of its long-term debt not recorded at fair value (see Note 6), and to its pension and postretirement plan assets (see Note 9).
Supplemental Cash Flow Information
In November 2021, the Company entered into an agreement with the DOT under the AMJP for a grant of up to $21,259. The receipt of the full award was primarily conditioned upon the Company committing to not furlough or lay off a defined group of employees during the six-month period of performance between November 2021 and May 2022. The Company received approximately $19,400 under the agreement, and, in July, received a letter from the DOT confirming that the Company had satisfied the reporting requirements under the AMJP. In the nine months ended December 31, 2022 and 2021, the Company recognized as a reduction in cost of sales approximately $5,300 and $2,700, respectively, the former representing the final balance of the earned grant benefit.
For the nine months ended December 31, 2022, the Company paid $3,838 for income taxes, net of income tax refunds received. For the nine months ended December 31, 2021, the Company paid $3,065 for income taxes, net of income tax refunds received.
3. DIVESTED OPERATIONS AND ASSETS HELD FOR SALE
Fiscal 2023 Divestitures
In January 2022, the Company’s Board of Directors committed to a plan to sell its manufacturing operations located in Stuart, Florida. In February 2022, the Company entered into a definitive agreement with the buyer of these manufacturing operations. This transaction closed in July 2022. Upon the completion of the sale of the Stuart manufacturing operations, the Company
11
recognized a gain of approximately $99,200, net of transaction costs. The purchase price included the assumption of certain liabilities of the Company; no cash proceeds were received in the transaction. The operating results of the Stuart, Florida, manufacturing operations are included within the Aerospace Structures reportable segment through the date of divestiture.
In the nine months ended December 31, 2022, the Company recognized a gain of approximately $4,500 from working capital settlements related to the fiscal 2022 divestitures described below.
Fiscal 2022 Divestitures
In May 2020, the Company’s Board of Directors committed to a plan to sell its composites manufacturing operations located in Milledgeville, Georgia and Rayong, Thailand. In August 2020, the Company entered into a definitive agreement with the buyer of the composites manufacturing operations in Georgia and Thailand. In February 2021, the Company entered into a definitive agreement to sell its large structure manufacturing operations in Red Oak, Texas, to the same buyer of the Milledgeville and Rayong composites manufacturing operations. These transactions closed in May 2021. Upon the completion of the sale of the composites and large structure manufacturing operations, the Company received proceeds of approximately $155,000 net of the purchase of a facility related to the divestiture and other transaction costs and recognized an additional loss of approximately $6,000, which is presented on the accompanying condensed consolidated statements of operations within loss on sale of assets and businesses for the three months ended June 30, 2021. The loss was primarily the result of changes in the working capital balances of the disposal group from March 31, 2021, to the date of divestiture. The operating results of these related operations are included within the Aerospace Structures reportable segment through the date of divestiture. As a result of the completed sale of these manufacturing operations, the Company recognized a pension curtailment charge of approximately $16,000 during the three months ended June 30, 2021.
In August 2021, the Company's Board of Directors committed to a plan to sell and license certain legacy product lines of the Company's Staverton, United Kingdom operations. The transaction includes the existing facility and select product lines associated with the site. The transaction closed in October 2021 for net proceeds of approximately $34,000, and the effect on earnings was insignificant. The operating results of the Staverton, United Kingdom, manufacturing operations were included within the Systems & Support reportable segment through the date of divestiture.
As a result of the fiscal 2022 divestitures described above, including routine closing working capital adjustments, the Company recognized losses of approximately $8,000 in the three months ended September 30, 2021.
4. REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS
Disaggregation of Revenue
The Company disaggregates revenue based on the method of measuring satisfaction of the performance obligation either over time or at a point in time. Additionally, the Company disaggregates revenue based upon the end market where products and services are transferred to the customer. The Company’s principal operating segments and related revenue are discussed in Note 11, Segments.
12
The following table shows disaggregated net sales satisfied overtime and at a point in time (excluding intercompany sales) for the three and nine months ended December 31, 2022 and 2021:
Three Months EndedDecember 31,
Nine Months EndedDecember 31,
Systems & Support
Satisfied over time
135,181
108,343
383,648
342,007
Satisfied at a point in time
149,648
127,000
428,632
397,804
Revenue from contracts with customers
284,829
235,343
812,280
739,811
Amortization of acquired contract liabilities
442
938
1,832
3,633
Total revenue
285,271
236,281
814,112
743,444
Aerospace Structures
37,692
81,511
155,740
308,667
5,892
1,457
15,987
21,168
43,584
82,968
171,727
329,835
329,847
The following table shows disaggregated net sales by end market (excluding intercompany sales) for the three and nine months ended December 31, 2022 and 2021:
OEM Commercial
77,221
65,585
232,806
175,567
OEM Military
60,040
58,844
174,525
203,383
MRO Commercial
83,301
51,706
230,591
170,504
MRO Military
52,373
53,014
145,275
168,789
Non-aviation
11,894
6,194
29,083
21,568
42,992
79,229
163,877
305,383
454
14,315
437
3,017
2,808
8,799
1,052
155
268
5,042
286
Contract Assets and Liabilities
Contract assets primarily represent revenues recognized for performance obligations that have been satisfied or partially satisfied but for which amounts have not been billed. This typically occurs when revenue is recognized over time but the Company's contractual right to bill the customer and receive payment is conditional upon the satisfaction of additional performance obligations in the contract, such as final delivery of the product. Contract assets are typically derecognized when billed in accordance with the terms of the contract. The Company pools contract assets that share underlying risk characteristics and records an allowance for expected credit losses based on a combination of prior experience, current economic conditions and management’s expectations of future economic conditions, and specific collectibility matters when they arise. Contract assets are presented net of this reserve
13
on the condensed consolidated balance sheets. For the three and nine months ended December 31, 2022 and 2021, credit loss expense and write-offs related to contract assets were immaterial.
Contract liabilities are recorded when customers remit contractual cash payments in advance of the Company satisfying performance obligations under contractual arrangements, including those with performance obligations to be satisfied over a period of time. Contract liabilities other than those pertaining to forward loss reserves are derecognized when or as revenue is recognized.
Contract modifications can also impact contract asset and liability balances. When contracts are modified to account for changes in contract specifications and requirements, the Company considers whether the modification either creates new or changes the existing enforceable rights and obligations. Contract modifications that are for goods or services that are not distinct from the existing contract, due to the significant integration with the original good or service provided, are accounted for as if they were part of that existing contract. The effect of a contract modification to an existing contract on the transaction price and the Company's measure of progress for the performance obligation to which it relates, is recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) on a cumulative catch-up basis. When the modifications include additional performance obligations that are distinct and at relative stand-alone selling price, they are accounted for as a new contract and performance obligation and are recognized prospectively.
Contract balances are classified as assets or liabilities on a contract-by-contract basis at the end of each reporting period. The following table summarizes the Company's contract assets and liabilities balances:
Change
101,893
6,753
(41,139
(172,862
131,723
Net contract asset (liability)
67,507
(70,969
138,476
During the nine months ended December 31, 2022, the Company recognized revenue due to changes in estimates associated with performance obligations satisfied or partially satisfied in previous periods of $13,360. The change in contract assets was not significant in the nine months ended December 31, 2022. The change in contract liabilities is the result of revenue recognized in excess of the receipt of additional customer advances as well as the extinguishment of approximately $103,803 of customer advance repayment obligations that were assumed by the buyer of the Stuart, Florida, manufacturing operations. For the nine months ended December 31, 2022, the Company recognized $43,823 of revenue that was included in the contract liability balance at the beginning of the period.
Performance Obligations
Customers generally contract with the Company for requirements in a segment relating to a specific program, and the Company’s performance obligations consist of a wide range of engineering design services and manufactured components, as well as spare parts and repairs for OEMs. A single contract may contain multiple performance obligations consisting of both recurring and nonrecurring elements.
As of December 31, 2022, the Company has the following unsatisfied, or partially unsatisfied, performance obligations that are expected to be recognized in the future as noted in the table below. The Company expects options to be exercised in addition to the amounts presented below.
Less than1 year
1-3 years
4-5 years
More than 5years
Unsatisfied performance obligations
1,336,674
859,518
445,179
27,982
3,995
14
5. INVENTORIES
Inventories are stated at the lower of cost (average-cost or specific-identification methods) or market. The components of inventories are as follows:
December 31,2022
Raw materials
52,218
44,841
Work-in-process, including manufactured and purchased components
302,964
269,368
Finished goods
21,278
19,472
Rotable assets
24,007
28,011
Total inventories
6. LONG-TERM DEBT
Long-term debt consists of the following:
Receivable securitization facility
Finance leases
14,813
16,492
Senior secured first lien notes due 2024
543,831
563,171
Senior secured notes due 2024
525,000
Senior notes due 2025
500,000
Less: debt issuance costs
(10,467
(15,173
1,608,177
1,589,490
Less: current portion
15
Receivables Securitization Program
In connection with the Company's receivables securitization facility (the "Securitization Facility"), the Company sells on a revolving basis certain eligible accounts receivable to Triumph Receivables, LLC, a wholly-owned special-purpose entity, which in turn sells a percentage ownership interest in the receivables to commercial paper conduits sponsored by financial institutions. The Company is the servicer of the trade accounts receivable under the Securitization Facility. Interest rates are based on the Bloomberg Short Term Bank Yield Index ("BSBY"), plus a 2.25% fee on the drawn portion and a fee ranging from 0.45% to 0.50% on the undrawn portion of the Securitization Facility. The drawn fee may be reduced to 2.00% depending on the credit rating of the Company. Collateralized letters of credit incur fees at a rate of 0.125%. The Company secures its trade accounts receivable, which are generally non-interest-bearing, in transactions that are accounted for as borrowings pursuant to ASC 860, Transfers and Servicing. The Company has established a letter of credit facility under the Securitization Facility. Under the provisions of the letter of credit facility, the Company may request the Securitization Facility’s administrator to issue one or more letters of credit that will expire no later than 12 months after the date of issuance, extension or renewal, as applicable.
As of December 31, 2022, the maximum amount available under the Securitization Facility was $100,000. The actual amount available under the Securitization Facility at any point in time is dependent upon the balance of eligible accounts receivable as well as the amount of letters of credit outstanding.
At December 31, 2022, there were $35,000 in borrowings and $21,295 in letters of credit outstanding under the Securitization Agreement, primarily to support insurance policies. The Securitization Facility expires in November 2024.
The agreements governing the Securitization Facility contain restrictions and covenants, including limitations on the making of certain restricted payments; creation of certain liens; and certain corporate acts such as mergers, consolidations and the sale of all or substantially all the Company's assets.
16
Senior Secured First Lien Notes due 2024
On August 17, 2020, the Company issued $700,000 principal amount of 8.875% Senior Secured First Lien Notes due June 1, 2024 (the “First Lien Notes”). The First Lien Notes were sold at 100% of the principal amount and have an effective interest yield of 8.875%. Interest is payable semiannually in cash in arrears on June 1 and December 1 of each year. The First Lien Notes are first lien secured obligations of the Company. The First Lien Notes are guaranteed on a full, senior secured, joint and several basis by each of the Company’s domestic restricted subsidiaries that guarantees either of the Company’s 2024 Notes and 2025 Notes, as defined below (the “Guarantor Subsidiaries”). In the future, each of the Company’s domestic restricted subsidiaries (other than any domestic restricted subsidiary that is a receivable subsidiary) that (1) is not an immaterial subsidiary, (2) becomes a borrower under any of its material debt facilities or (3) guarantees (a) any of the Company’s indebtedness or (b) any indebtedness of the Company’s domestic restricted subsidiaries, in the case of either (a) or (b), incurred under any of the Company’s material debt facilities, will guarantee the First Lien Notes. Under certain circumstances, the guarantees may be released without action by, or consent of, any holder of the First Lien Notes.
The Company may redeem the First Lien Notes, in whole or in part, at any time or from time to time on or after February 1, 2023, at specified redemption prices, plus accrued and unpaid interest, if any, to the redemption date. At any time or from time to time prior to February 1, 2023, the Company may redeem the First Lien Notes, in whole or in part, at a redemption price equal to 100% of their principal amount plus a make whole premium, together with accrued and unpaid interest, if any, to the redemption date. In addition, the Company may redeem up to 40% of the aggregate principal amount of the outstanding First Lien Notes prior to June 1, 2023, with the net cash proceeds from certain equity offerings at a redemption price equal to 108.875% of their principal amount, together with accrued and unpaid interest, if any, to the redemption date.
If the Company experiences specific kinds of changes of control, the Company is required to offer to purchase all of the First Lien Notes at a purchase price of 101% of their principal amount, plus accrued and unpaid interest, if any, to the date of purchase.
The First Lien Notes Indenture contains covenants that, among other things, limit the ability of the Company and its restricted subsidiaries to: (i) incur additional indebtedness; (ii) pay dividends or make other distributions; (iii) make other restricted payments and investments; (iv) create liens; (v) incur restrictions on the ability of restricted subsidiaries to pay dividends or make certain other payments; (vi) sell assets, including capital stock of restricted subsidiaries; (vii) enter into sale and leaseback transactions; (viii) merge or consolidate with other entities; and (ix) enter into transactions with affiliates. In addition, the First Lien Notes Indenture requires, among other things, the Company to provide financial and current reports to holders of the First Lien Notes or file such reports electronically with the SEC. Furthermore, the First Lien Notes Indenture requires that the future net proceeds from certain asset sales will be required to repay the First Lien Notes at a premium of 106.656%, until the aggregate principal amount of Notes outstanding is $350,000 or less, provided that the Company may retain the first $100,000 of such net proceeds (subject to compliance with the asset sale covenants in the Company’s other outstanding indentures) or use it for certain other permitted purposes. These covenants are subject to a number of exceptions, limitations and qualifications set forth in the Indenture, as well as suspension periods in certain circumstances. Upon the completion of the sale of the composites and large structure manufacturing operations as disclosed in Note 3, the Company surpassed the $100,000 threshold of net proceeds from certain asset sales resulting in a required redemption of $112,511 of the outstanding principal balance and a premium of approximately $7,489 in the three months ended June 30, 2021. As a result of the completion of the sale and license of certain legacy product lines of the Company's Staverton, United Kingdom operations, the Company was required to pay an additional required redemption of $24,318 of the outstanding principal balance and a premium of approximately $1,619 in the three months ended December, 31, 2021. In the nine months ended December 31, 2022, the Company sold intellectual property that required redemption of $19,340 of the outstanding principal balance and payment of a premium of approximately $1,287.
Senior Secured Notes Due 2024
On September 23, 2019, the Company issued $525,000 principal amount of 6.250% Senior Secured Notes due September 15, 2024 (the "2024 Notes"). The 2024 Notes were sold at 100% of principal amount and have an effective interest yield of 6.250%. Interest on the 2024 Notes is payable semiannually in cash in arrears on March 15 and September 15 of each year. The 2024 Notes are secured by second-priority liens on all of the Company's and the Guarantor Subsidiaries' assets that secure all of the indebtedness under the First Lien Notes and certain hedging and cash management obligations. The Company has the ability to incur additional first and/or second lien debt under certain circumstances.
Senior Notes Due 2025
On August 17, 2017, the Company issued $500,000 principal amount of 7.750% Senior Notes due August 15, 2025 (the "2025 Notes"). The 2025 Notes were sold at 100% of principal amount and have an effective interest yield of 7.750%.
17
Interest on the 2025 Notes accrues at the rate of 7.750% per annum and is payable semiannually in cash in arrears on February 15 and August 15 of each year.
Financial Instruments Not Recorded at Fair Value
Carrying amounts and the related estimated fair values of the Company's long-term debt not recorded at fair value in the consolidated financial statements are as follows:
CarryingValue
FairValue
1,529,544
1,639,248
The fair value of the long-term debt was calculated based on either interest rates available for debt with terms and maturities similar to the Company's existing debt arrangements or broker quotes on the Company's existing debt (Level 2 inputs).
Interest paid on indebtedness during the nine months ended December 31, 2022 and 2021, amounted to $89,225 and $110,488, respectively. The interest paid during the nine months ended December 31, 2022 and 2021 included the redemption premiums on the First Lien Notes amounted to $1,287 and $9,108, respectively.
7. EARNINGS PER SHARE
The calculation of basic earnings per share is based on the weighted average number of common shares considered outstanding during the periods. The calculation of diluted earnings per share reflects the effect of all potentially dilutive securities (principally outstanding warrants and outstanding restricted stock units). As disclosed in Note 2, the warrants permit the tendering of Designated Notes in payment of the exercise price. In computing diluted EPS, the Company applies the if-converted method to the warrants and such warrants are assumed to be exercised and the Designated Notes are assumed to be tendered unless tendering cash would be more advantageous to the warrant holder. Interest (net of tax) on any Designated Notes assumed to be tendered is added back as an adjustment to the numerator. The numerator also is adjusted for any nondiscretionary adjustments based on income (net of tax) including, for example, warrant remeasurement gains and losses recognized in the period. If cash exercise is more advantageous, the Company applies the treasury stock method to the warrants when calculating diluted EPS. The following is a reconciliation between the weighted average outstanding shares used in the calculation of basic and diluted earnings per share:
(in thousands, except per share amounts)
Numerator:
Numerator for basic earnings per share:
Effect of Dilutive Securities:
(5,730
Numerator for diluted earnings per share:
Income available to common stockholders after assumed conversions
5,222
101,406
Denominator:
Denominator for basic earnings per share
Weighted average common shares outstanding - basic
3,169
1,056
Restricted stock units
219
475
321
Dilutive potential common shares
3,388
1,377
Weighted average common shares outstanding - diluted
Earnings (loss) per share:
Basic earnings per share
Diluted earnings per share
18
(1) For the three and nine months ended December 31, 2022 and 2021, the shares that could potentially dilute earnings per share in the future but were not included in diluted weighted average common shares outstanding because to do so would have been anti-dilutive were immaterial.
8. INCOME TAXES
The Company follows the Income Taxes topic of ASC 740, which prescribes a recognition threshold and measurement attribute criteria for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return, as well as guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company's policy is to release the tax effects from accumulated other comprehensive income when all of the related assets or liabilities that gave rise to the accumulated other comprehensive income have been derecognized.
The Company has classified uncertain tax positions as noncurrent income tax liabilities unless expected to be paid in one year. Penalties and tax-related interest expense are reported as a component of income tax expense and are not significant.
As of December 31, 2022 and March 31, 2022, the total amount of unrecognized tax benefits was $11,981 and $11,800, respectively, most of which would impact the effective rate, if recognized. The Company does not anticipate that total unrecognized tax benefits will be reduced in the next 12 months.
As of December 31, 2022, the Company has a valuation allowance against principally all of its net deferred tax assets given insufficient positive evidence to support the realization of the Company’s deferred tax assets. The Company intends to continue maintaining a valuation allowance on its deferred tax assets until there is sufficient positive evidence to support the reversal of all or some portion of this allowance. A reduction in the valuation allowance could result in a significant decrease in income tax expense in the period that the release is recorded. However, the exact timing and amount of the reduction in its valuation allowance is unknown at this time and will be subject to the earnings level the Company achieves during fiscal 2023 and future periods.
The effective income tax rate for the three months ended December 31, 2022, was 3.5% as compared with 13.2% for the three months ended December 31, 2021. The effective income tax rate for the nine months ended December 31, 2022, was 3.5% as compared with (14.6)% for the nine months ended December 31, 2021. For the three and nine months ended December 31, 2022, the effective income tax rate reflected a limitation on the recognition of tax benefits due to the full valuation allowance.
With few exceptions, the Company is no longer subject to U.S. federal, state, or local income tax examinations for fiscal years ended before March 31, 2014, or foreign income tax examinations by tax authorities for fiscal years ended before March 31, 2013.
As of December 31, 2022, the Company settled its only foreign income tax examination. The Company believes appropriate provisions for all outstanding issues have been made for all jurisdictions and all open years.
9. PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
The Company sponsors several defined benefit pension plans covering some of its employees. Most employees are ineligible to participate in the plans or have ceased to accrue additional benefits under the plans based upon their service to the Company or years of service accrued under the defined benefit pension plans. Benefits under the defined benefit plans are based on years of service and, for most non-represented employees, on average compensation for certain years. It is the Company’s policy to fund at least the minimum amount required for all qualified plans, using actuarial cost methods and assumptions acceptable under U.S. Government regulations (and for non-U.S. plans, acceptable under local regulations), by making payments into a separate trust.
In addition to the defined benefit pension plans, the Company provides certain healthcare benefits for eligible retired employees. Such benefits are unfunded. No active employees are eligible for these benefits. The vast majority of eligible retirees receive a fixed-dollar benefit they can use to purchase healthcare services. A small number of eligible retirees receive traditional retiree medical benefits for which the company pays all premiums. All retirees who are eligible for these traditional benefits are Medicare-eligible. Current plan documents reserve the right to amend or terminate the plans at any time, subject to applicable collective bargaining requirements for represented employees.
In accordance with the Compensation – Retirement Benefits topic of ASC 715, the Company has recognized the funded status of the benefit obligation as of the date of the last re-measurement, on the accompanying condensed consolidated balance sheets. The funded status is measured as the difference between the fair value of the plan’s assets and the pension benefit obligation or accumulated postretirement benefit obligation, of the plan. In order to recognize the funded status, the Company determined the fair value of the plan assets. The majority of the plan assets are publicly traded investments, which were valued based on the market price as of the date of re-measurement. Investments that are not publicly traded were valued based on the estimated fair value of those investments based on the Company's evaluation of data from fund managers and comparable market data.
19
Net Periodic Benefit Plan Costs
The components of net periodic benefit income for the Company's postretirement benefit plans are shown in the following table:
Pension Benefits
Components of net periodic benefit income:
Service cost
169
183
511
562
Interest cost
16,290
11,695
48,869
35,207
Expected return on plan assets
(30,326
(33,361
(90,973
(100,188
Amortization of prior service credits
26
77
93
Amortization of net loss
7,725
9,614
23,174
28,803
Curtailment loss
16,024
Settlement loss
3,826
Special termination benefits
196
Net periodic benefit income
(6,116
(11,843
(18,342
(15,477
The Company recognized net periodic benefit income from its other postretirement benefits plan of approximately $2,291 and $6,872 for the three and nine months ended December 31, 2022, respectively, and approximately $2,349 and $7,047 for the three and nine months ended December 31, 2021.
10. STOCKHOLDERS' DEFICIT
20
Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive loss ("AOCI") by component for the three and nine months ended December 31, 2022 and 2021, were as follows:
CurrencyTranslationAdjustment
Unrealized Gainsand Losses onDerivativeInstruments
Defined BenefitPension Plansand OtherPostretirementBenefits
Total (1)
(70,748
(1,481
(404,504
Other comprehensive (loss) income before reclassifications
16,424
Amounts reclassified from AOCI
(2)
5,101
Net current period OCI
(56,698
671
(399,181
(45,104
(890
(457,211
(503,205
Other comprehensive income before reclassifications
(114
7,013
(45,880
(479
(449,947
(496,306
(47,933
(270
(415,151
(6,655
14,801
(42,161
1,015
(489,046
(530,192
4,051
28,659
29,835
11. SEGMENTS
The Company reports financial performance based on the following two reportable segments: Systems & Support and Aerospace Structures. The Company’s reportable segments are aligned with how the business is managed, and the Company's views of the markets it serves. The Chief Operating Decision Maker (the "CODM") evaluates performance and allocates resources based upon review of segment information. The CODM utilizes earnings before interest, income taxes, depreciation and amortization, and pension (“Adjusted EBITDAP”) as a primary measure of segment profitability to evaluate performance of its segments and allocate resources.
Segment Adjusted EBITDAP is total segment revenue reduced by operating expenses (less depreciation and amortization) identifiable with that segment. Corporate includes general corporate administrative costs and any other costs not identifiable with one of the Company’s segments.
The Company does not accumulate net sales information by product or service or groups of similar products and services, and therefore the Company does not disclose net sales by product or service because to do so would be impracticable.
21
Selected financial information for each reportable segment is as follows:
Three Months Ended December 31, 2022
Corporate &Eliminations
Systems &Support
AerospaceStructures
Net sales to external customers
Intersegment sales (eliminated in consolidation)
(29
22
Segment profit and reconciliation to consolidated income before income taxes:
Adjusted EBITDAP
55,684
49,971
5,713
Reconciliation of segment profit to income before income taxes
(8,624
(514
(7,419
(691
(36,361
Corporate expenses
(10,851
Share-based compensation expense
Loss on sale of assets and businesses
(720
8,576
(1,441
5,537
Income before income taxes
Total capital expenditures
5,107
81
4,459
567
86,534
1,382,952
127,806
Three Months Ended December 31, 2021
47,043
47,450
(407
(11,659
(733
(7,821
(3,105
(32,319
(5,533
(2,592
14,400
(1,935
8,336
7,984
348
Nine Months Ended December 31, 2022
(49
169,061
140,172
28,889
(27,115
(1,609
(22,447
(3,059
(100,726
(41,395
(6,420
Gain on sale of assets and businesses
103,163
25,725
Consideration payable to customer related to divestiture
(17,185
12,274
190
11,046
1,038
Nine Months Ended December 31, 2021
(47
31
159,327
135,345
23,982
Reconciliation of segment profit to loss before income taxes
(40,035
(24,765
(12,678
(105,060
(36,164
(7,664
(13,629
3,645
23,127
(11,624
Loss before income taxes
15,817
518
11,741
3,558
23
During the three months ended December 31, 2022 and 2021, the Company had foreign sales of $77,626 and $73,093, respectively. During the nine months ended December 31, 2022 and 2021, the Company had foreign sales of $221,034 and $231,136, respectively.
12. COMMITMENTS AND CONTINGENCIES
In the ordinary course of business, the Company is involved in disputes; claims; and lawsuits with employees, suppliers, and customers; as well as governmental and regulatory inquiries. Some may involve claims or potential claims of substantial damages, fines, penalties, or injunctive relief. While the Company cannot predict the outcome of any pending or future litigation or proceeding and no assurances can be given, the Company does not believe that any pending matter will have a material effect, individually or in the aggregate, on its financial position or results of operations.
As the Company completes the disposal of certain facilities, it may be exposed to additional costs such as environmental remediation obligations, lease termination costs, or customer or supplier claims which may have a material effect on its financial position or results of operations when such matters arise and a reasonable estimate of the costs can be made. For example, in the nine months ended December 31, 2022, the Company withdrew from a multiemployer pension plan for the benefit of certain represented employees as part of its exit of the Spokane, Washington, composites manufacturing operations. Under the terms of the multiemployer pension plan, it is reasonably possible that the Company may trigger a withdrawal liability related to the exit of the related facilities and termination of the affected employees. The amount of this potential liability is determined based on the funded status of the plan as of the last day of the plan year immediately preceding the date of the withdrawal. The funded status of the plan is measured by estimating the value of the plan's assets and liabilities, and these values can change significantly based on market conditions and changes in actuarial assumptions made by the plan sponsor. If a withdrawal liability is triggered, the obligation would likely be satisfied through annual payments over a period of at least ten years.
24
Management's Discussion and Analysis of
Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with the condensed consolidated financial statements and notes thereto contained elsewhere herein.
OVERVIEW
Business
We are a major supplier to the aerospace industry and have two reportable segments: (i) Systems & Support, whose companies’ revenues are derived from integrated solutions, including design, development and support of proprietary components, subsystems and systems, production of complex assemblies using external designs, as well as full life cycle solutions for commercial, regional, and military aircraft; and (ii) Aerospace Structures, whose companies supply commercial, business, and regional manufacturers with large metallic structures and produce close-tolerance parts primarily to customer designs and model-based definition, including a wide range of aluminum, hard metal, and composite structure capabilities. Subsequent to the Stuart, Florida, manufacturing divestiture described below, the remaining operations of Aerospace Structures are those that supply commercial and regional manufacturers with aircraft interior systems.
Divestitures
During the fiscal year ended March 31, 2022, we completed the divestiture of our composites manufacturing operations located in Milledgeville, Georgia, and Rayong, Thailand, as well as our large structure manufacturing operations located in Red Oak, Texas. The operating results associated with the composites and large structure manufacturing operations were included within Aerospace Structures through the date of divestiture. Refer to Note 3 for a discussion of other less significant divestitures occurring in fiscal 2022.
As disclosed in Note 3, in July 2022, we completed the sale of our manufacturing operations located in Stuart, Florida, and recognized a gain in the second quarter of fiscal 2023. The Stuart operations specialized in the assembly of large, complex metallic structures such as wing and fuselage assemblies. As a result of the completion of this sale, we have exited our structures business and reshaped our portfolio of companies to consist primarily of businesses providing systems and aftermarket services. The operating results associated with the Stuart operations are included within Aerospace Structures through the date of divestiture.
Summary of Significant Financial Results
Significant financial results for the third quarter of the fiscal year ending March 31, 2023, include:
Aviation Manufacturing Jobs Protection Program
As disclosed in Note 2, in November 2021, we entered into an agreement with the Department of Transportation (“DOT”) under the Aviation Manufacturing Jobs Protection Program (“AMJP”). We received total proceeds under this program of $19.4 million, of which approximately $8.8 million was received in the three months ended June 30, 2022. In July 2022, we received a letter from the DOT confirming that we had satisfied the reporting requirements under the AMJP. In the nine months ended December 31, 2022 and 2021, we recognized the approximately $5.3 million and $2.7 million, respectively, of the grant benefit as a reduction in cost of sales.
(continued)
Warrants Distribution
As disclosed in Note 2, on December 19, 2022, we issued approximately 19.5 million Warrants to holders of record of common stock as of the close of business on December 12, 2022. Each Warrant represents the right to purchase initially one share of common stock at an exercise price of $12.35 per Warrant. Payment for shares of common stock on exercise of Warrants may be in (i) cash or (ii) under certain circumstances, Designated Notes (as defined in Note 2). Assuming that all Warrants distributed are fully exercised for cash, we would receive proceeds of approximately $270.0 million in the aggregate, net of transaction costs. We intend to use any cash proceeds for general corporate purpose, which may include the repayment of debt. Any Designated Notes received upon exercise of a Warrant are expected to be retired and cancelled by the Company. If holders exercise Warrants through the surrender of Designated Notes, the amount of the Company's outstanding debt will be reduced. Following the issuance on December 19, 2022 through December 31, 2022, no Warrants have been exercised.
Significant Developments in Key Programs
Discussion of significant developments on key programs is included below.
Boeing 767
Boeing's 767 program includes the commercial program and a derivative to support the related tanker program. The 767 currently has a production rate of three aircraft per month. Approximately 5% of our revenue in the nine months ended December 31, 2022, was generated by 767 production from our Stuart, Florida, operations, which, as disclosed above, was sold as of July 1, 2022. The impact of 767 production on our operating income was not significant.
Boeing 747-8
Production, production facility exit plans, and storage facility exit plans are complete on the 747-8 program.
With the exception of the impact of divestitures, none of the programs noted above individually are expected to have a material impact on our net revenues. These programs do have the potential, either individually or in the aggregate, to materially and negatively impact our consolidated results of operations if future changes in estimates result in the need for a forward loss provision. Absent any such loss provisions, we do not anticipate that any of these programs will significantly dilute our future consolidated margins.
RESULTS OF OPERATIONS
The following includes a discussion of our consolidated and business segment results of operations. Our diverse structure and customer base do not provide for precise comparisons of the impact of price and volume changes to our results. However, we have disclosed the significant variances between the respective periods.
Non-GAAP Financial Measures
We prepare and publicly release annual audited and quarterly unaudited financial statements prepared in accordance with U.S. GAAP. In accordance with Securities and Exchange Commission (the "SEC") rules, we also disclose and discuss certain non-GAAP financial measures in our public filings and earning releases. Currently, the non-GAAP financial measures that we disclose are Adjusted EBITDA, which is our net loss before interest, income taxes, amortization of acquired contract liabilities, legal settlements, gains/loss on divestitures, gains/losses on warrant remeasurements and warrant-related transaction costs, share-based compensation expense, depreciation and amortization; and Adjusted EBITDAP, which is Adjusted EBITDA, before pension expense or benefit, including the effects of curtailments, settlements, and other early retirement incentives. We disclose Adjusted EBITDA on a consolidated and Adjusted EBITDAP on a consolidated and a reportable segment basis in our earnings releases, investor conference calls and filings with the SEC. The non-GAAP financial measures that we use may not be comparable to similarly titled measures reported by other companies. Also, in the future, we may disclose different non-GAAP financial measures in order to help our investors more meaningfully evaluate and compare our future results of operations with our previously reported results of operations.
We view Adjusted EBITDA and Adjusted EBITDAP as operating performance measures and, as such, we believe that the U.S. GAAP financial measure most directly comparable to such measures is net income. In calculating Adjusted EBITDA and Adjusted EBITDAP, we exclude from net income the financial items that we believe should be separately identified to provide additional analysis of the financial components of the day-to-day operation of our business. We have outlined below the type and scope of these exclusions and the material limitations on the use of these non-GAAP financial measures as a result of these exclusions. Adjusted EBITDA and Adjusted EBITDAP are not measurements of financial performance under U.S. GAAP and should not be considered as a measure of liquidity, as an alternative to net income, or as an indicator of any other measure of performance derived in accordance with U.S. GAAP. Investors and potential investors in our securities should not rely on Adjusted EBITDA or Adjusted EBITDAP as a substitute for any U.S. GAAP financial measure, including net income. In addition, we urge investors and potential investors in our securities to carefully review the reconciliation of Adjusted EBITDA and Adjusted EBITDAP to net income set forth below, in our earnings releases, and in other filings with the SEC and to carefully review the U.S. GAAP financial information included as part of our Quarterly Reports on Form 10-Q and our Annual Reports on Form 10-K that are filed with the SEC, as well as our quarterly earnings releases, and compare the U.S. GAAP financial information with our Adjusted EBITDA and Adjusted EBITDAP.
Adjusted EBITDA and Adjusted EBITDAP are used by management to internally measure our operating and management performance and by investors as a supplemental financial measure to evaluate the performance of our business that, when viewed with our U.S. GAAP results and the accompanying reconciliation, we believe provides additional information that is useful to gain an understanding of the factors and trends affecting our business. We have spent more than 25 years expanding our product and service capabilities, partially through acquisitions of complementary businesses. Due to the expansion of our operations, which included acquisitions, our net income has included significant charges for depreciation and amortization. Adjusted EBITDA and Adjusted EBITDAP exclude these charges and provide meaningful information about the operating performance of our business, apart from charges for depreciation and amortization. We believe the disclosure of Adjusted EBITDA and Adjusted EBITDAP helps investors meaningfully evaluate and compare our performance from quarter to quarter and from year to year. We also believe Adjusted EBITDA and Adjusted EBITDAP are measures of our ongoing operating performance because the isolation of noncash charges, such as depreciation and amortization, and nonoperating items, such as interest, income taxes, pension and other postretirement benefits, provides additional information about our cost structure and, over time, helps track our operating progress. In addition, investors, securities analysts, and others have regularly relied on Adjusted EBITDA and Adjusted EBITDAP to provide financial measures by which to compare our operating performance against that of other companies in our industry.
Set forth below are descriptions of the financial items that have been excluded from our net income to calculate Adjusted EBITDA and Adjusted EBITDAP and the material limitations associated with using these non-GAAP financial measures as compared with net income from continuing operations:
27
Management compensates for the above-described limitations of using non-GAAP measures by using a non-GAAP measure only to supplement our GAAP results and to provide additional information that is useful to gain an understanding of the factors and trends affecting our business.
The following table shows our Adjusted EBITDA and Adjusted EBITDAP reconciled to our net income (loss) for the indicated periods (in thousands):
Net income (loss) (U.S. GAAP measure)
Interest expense and other
Pension settlements, curtailments, and other pension related charges
Consideration Payable to customer related to divestiture
17,185
Loss (gain) on sale of assets and businesses, net
2,592
(442
(938
Adjusted EBITDA (non-GAAP measure)
53,409
55,910
153,391
166,336
Non-service defined benefit income (excluding settlements)
(43,173
Adjusted EBITDAP (non-GAAP measure)
44,833
41,510
127,666
123,163
The following tables show our Adjusted EBITDAP by reportable segment reconciled to our operating income (loss) for the indicated periods (in thousands):
Corporate/Eliminations
Operating income (loss)
42,994
5,022
(12,975
7,419
691
514
28
40,567
(3,512
(8,858
7,821
3,105
733
119,557
8,645
53,739
22,447
3,059
1,609
114,213
11,316
(60,049
(3,633
(12
24,765
12,678
The fluctuations from period to period within the amounts of the components of the reconciliations above are discussed further below within Results of Operations.
Three months ended December 31, 2022, compared with three months ended December 31, 2021
(in thousands)
Segment operating income
48,016
37,055
Corporate expense
Total operating income
Net Sales
Organic sales adjusted for intersegment sales increased $55.5 million, or 20.7%, offset by declines from the divestiture of our Stuart manufacturing operations and Staverton, United Kingdom divestiture of $49.3 million. Changes in sales on sunsetting programs (i.e., 747-8 and G280) were not significant. Organic sales increased primarily as a result of the continued pandemic recovery driving volume for both commercial OEM and aftermarket sales, and increased sales on the V-22 military rotorcraft due
29
to timing. Total nonrecurring revenues for the three months ended December 31, 2022, were $7.1 million, as compared with $4.5 million in total nonrecurring revenues for the three months ended December 31, 2021.
Cost of Sales and Gross Margin
Organic cost of sales adjusted for intersegment sales increased $51.7 million, or 27.8%, offset by declines from the divestiture of our Stuart manufacturing operations and Staverton, United Kingdom divestiture of $49.5 million. Changes in cost of sales on sunsetting programs was not significant. Organic cost of sales increased primarily due to the increased volumes described above, approximately $5.7 million in prior period reductions in acquired contract reserves, and approximately $2.7 million in prior period grant benefits under the AMJP agreement with the DOT the benefits of which, as of September 30, 2022, had been fully earned and recognized. Organic gross margin for the three months ended December 31, 2022, was 26.4% compared with 30.5% for the three months ended December 31, 2021. The organic gross margin for the three months ended December 31, 2022 decreased due to the change in the mix of sales, including a licensing transaction in the prior period, and the prior period reductions in acquired contract reserves.
Cumulative catch-up adjustments for the three months ended December 31, 2022, did not have a significant impact on gross margin. Gross margins for the three months ended December 31, 2021, included net unfavorable cumulative catch-up adjustments of $4.6 million.
Segment Operating Income
Organic segment operating income increased by $11.4 million, or 34.3%, primarily due to the increased gross profit and margins described above, as well as decreased administrative human capital related costs of approximately $2.1 million and decreased restructuring of approximately $4.1 million related to a facility closure in the prior year. Changes in operating income from divestitures and sunsetting programs was not significant.
Corporate Expense
Corporate expenses increased primarily as a result of the timing of due diligence costs of approximately $2.7 million.
Interest Expense and Other
Interest expense and other increased due to increased foreign exchange losses, partially offset by lower interest on lower relative debt levels as a result of prior year redemptions.
Non-service Defined Benefit Income
Non-service defined benefit income decreased primarily due to changes in actuarial assumptions and experience.
Income Taxes
The effective income tax rate for the three months ended December 31, 2022, was 3.5% compared with 13.2% for the three months ended December 31, 2021. For the three months ended December 31, 2022, the effective tax rate reflected a limitation on the recognition of tax benefits due to the full valuation allowance.
Business Segment Performance — Three months ended December 31, 2022, compared with three months ended December 31, 2021
We report our financial performance based on the following two reportable segments: Systems & Support and Aerospace Structures. Our Chief Operating Decision Maker ("CODM") utilizes Adjusted EBITDAP as a primary measure of profitability to evaluate performance of its segments and allocate resources.
The results of operations among our reportable segments vary due to differences in competitors, customers, extent of proprietary deliverables and performance. For example, Systems & Support, which generally includes proprietary products and/or arrangements where we become the primary source or one of a few primary sources to our customers, our unique engineering and manufacturing capabilities command a higher margin.
Refer to Note 1 for further details regarding the operations and capabilities of each of our reportable segments.
We currently generate a majority of our revenue from sales to OEMs and aftermarket MRO services in the commercial airline and military and defense markets. Our growth and financial results are largely dependent on continued demand for our products and services within these markets. If any of the related industries experiences a downturn, our clients in these sectors may conduct less business with us. The loss of one or more of our major customers or an economic downturn in the commercial airline or the military and defense markets could have a material adverse effect on our business.
30
% Change
% of Total Sales
NET SALES
285,278
20.7
%
86.7
74.0
43,606
(47.4
)%
13.3
26.0
Elimination of inter-segment sales
(0.0
Total net sales
3.0
100.0
% of Segment Sales
SEGMENT OPERATING INCOME (LOSS)
6.0
15.1
17.2
243.0
11.5
(4.2
Corporate
(46.5
n/a
Total segment operating income (loss)
24.3
10.7
8.8
5.3
17.5
20.2
1503.7
13.1
(0.5
(96.1
8.0
13.7
13.0
Systems & Support:
Net sales adjusted for intersegment sales increased by $49.0 million, or 20.7%, primarily as a result of the continued pandemic recovery driving volume for both commercial OEM and aftermarket sales, and increased sales on the V-22 military rotorcraft due to timing. Nonrecurring revenues for the three months ended December 31, 2022, were not significant, as compared with $4.0 million in total nonrecurring revenues for the three months ended December 31, 2021.
Cost of sales adjusted for intersegment sales increased by $47.9 million, or 30.3% primarily due to the increased volumes described above as well as approximately $5.7 million in prior period reductions in acquired contract reserves, and approximately $2.7 million in prior period grant benefits under the AMJP agreement with the DOT the benefits of which, as of September 30, 2022, had been fully earned and recognized. Gross margin for the three months ended December 31, 2022, was 27.9% compared with 33.2% for the three months ended December 31, 2021. Organic gross margin decreased as a result of changes in sales mix, including a licensing transaction in the prior period, and the prior period reductions in acquired contract reserves.
Operating Income and Adjusted EBITDAP
Operating income increased by $2.4 million, or 6.0% primarily due to the increased gross profit described above, as well as decreased administrative human capital related costs of $2.3 million. The increase in Adjusted EBITDAP year over year is due to the same factors that increased operating income.
Operating Margin and Adjusted EBITDAP Margin
Operating income and Adjusted EBITDAP as a percentage of segment sales both decreased due to the factors described above.
Aerospace Structures:
Organic net sales increased by $6.5 million, or 20.9%, offset by declines from the divestiture of our Stuart manufacturing operations of $49.3 million. Changes in sales on sunsetting programs (i.e., 747-8 and G280) were not significant. Organic net sales increased primarily due to increased OEM volume on the 737. Nonrecurring revenues for the three months ended December 31, 2022, were $7.1 million, as compared with $0.5 million in total nonrecurring revenues for the three months ended December 31, 2021.
Organic cost of sales increased by $3.9 million, or 13.9%, offset by declines from the divestiture of our Stuart manufacturing operations of $49.5 million. Changes in sales on sunsetting programs (i.e., 747-8 and G280) were not significant. Organic gross margin for the three months ended December 31, 2022, was 15.5% compared with 10.3% for the three months ended December 31, 2021, increasing primarily due to the increased volumes above, and a reduction in losses from our Spokane, Washington, manufacturing operations the exit of which is nearing completion in the current period. Cumulative catch-up adjustments for the three months ended December 31, 2022, did not have a significant impact on gross margin. The net unfavorable cumulative catch-up adjustment for the three months ended December 31, 2021, was $4.9 million.
Organic operating income increased by $9.0 million, or 124.3%, primarily due to the organic gross margin improvements noted above, as well as decreased restructuring costs of $4.1 million. The increase in Adjusted EBITDAP is primarily due to increased operating income.
Operating income and Adjusted EBITDAP as a percentage of segment sales increased due to the increased gross margins described above.
Nine months ended December 31, 2022, compared with nine months ended December 31, 2021
128,202
125,529
Corporate income (expense)
Organic sales adjusted for intersegment sales increased $107.8 million, or 13.1%, offset by declines from approximately $17.2 million in consideration payable to a customer recognized in the three months ended June 30, 2022, related to the divestiture of our Stuart manufacturing operations, along with sales decreases from recent divestitures of $157.0 million, and sunsetting programs (i.e., 747-8 and G280) of $21.0 million. Organic sales increased primarily due to increased production rates on commercial OEM, primarily narrow body platforms; commercial repair and overhaul services; and an intellectual property transaction. Net sales for the nine months ended December 31, 2022, included $28.5 million in total nonrecurring revenues, as compared with $21.1 million in total nonrecurring revenues for the nine months ended December 31, 2021.
32
Organic cost of sales adjusted for intersegment sales increased $80.3 million, or 13.6%, offset by declines from the cost of sales of recent divestitures of $125.6 million and sunsetting programs of $22.4 million. Organic cost of sales increased primarily due to the increased sales volume noted above as well as approximately $24.9 million in prior period reductions in acquired contract reserves. These increases were partially offset by the increased recognition of grant benefits under the AMJP agreement with the DOT of approximately $2.6 million and prior period increases in inventory reserves. Organic gross margin for the nine months ended December 31, 2022, was 28.4% compared with 28.7% for the nine months ended December 31, 2021, down primarily due to changes in sales mix and prior period acquired contract reserve adjustments, partially offset by the margin benefits from the AMJP grant, current period sale of intellectual property, and a reduction in losses from our Spokane, Washington, manufacturing operations.
Gross margin for the nine months ended December 31, 2022, included net favorable cumulative catch-up adjustments on long-term contracts of $20.2 million. The favorable cumulative catch-up adjustments to operating income included gross favorable adjustments of $25.0 million and gross unfavorable adjustments of $4.9 million. Gross margins for the nine months ended December 31, 2021, included net favorable cumulative catch-up adjustments of $13.1 million.
Organic segment operating income increased by $41.7 million, or 48.1%, due to the organic gross margin improvements described above, as well as decreased restructuring of approximately $9.3 million related to a facility closure, administrative human capital related costs of approximately $6.6 million partially offset by increased travel expense of approximately $1.1 million. This increased organic segment operating income was offset by approximately $21.8 million in decreases from divestitures and sunsetting programs and $17.2 million from the consideration payable to a customer.
Corporate Income (Expense)
The corporate income (expenses) increased primarily due to change in gain/loss on sale of assets and businesses of $116.8 million.
Interest expense and other decreased due to lower relative debt levels as a result of prior period redemptions, partially offset by increased foreign exchange losses.
Non-service defined benefit income increased primarily due the prior period recognition of curtailment and settlement losses of approximately $20.0 million in the aggregate upon the completion of the composites and large structure manufacturing divestitures and the settlement of the fully-funded pension obligation it had retained subsequent to its fiscal year 2019 divestiture of Triumph Geared Solutions - Toronto, partially offset by decreases due to changes in actuarial assumptions and experience.
The effective income tax rate for the nine months ended December 31, 2022, was 3.5% compared with (14.6)% for the nine months ended December 31, 2021. For the nine months ended December 31, 2022, the effective tax rate reflected a limitation on the recognition of tax benefits due to the full valuation allowance.
Business Segment Performance — Nine months ended December 31, 2022, compared with nine months ended December 31, 2021
814,119
743,475
9.5
82.6
69.3
171,769
329,863
(47.9
17.4
30.7
(4.3
(8.2
33
4.7
14.7
15.4
(23.6
5.0
3.4
189.5
177.9
18.5
6.1
3.6
17.3
18.3
20.5
16.8
7.3
(14.5
3.7
Organic net sales adjusted for intersegment sales increased by $82.4 million, or 11.3%, partially offset by declines from the Staverton, United Kingdom, divestiture of $11.7 million. Organic sales increased primarily as a result of the continued pandemic recovery driving volume for both commercial OEM and aftermarket sales, increased sales on the V-22 military rotorcraft due to timing, and approximately $15.9 million recognized as a result of a nonrecurring intellectual property transaction partially offset by decreased volume on other military rotorcraft programs and approximately $4.0 million as a result of a prior period nonrecurring intellectual property transaction.
Organic cost of sales adjusted for intersegment sales increased by $75.8 million, or 15.2%, partially offset by declines from the Staverton, United Kingdom, divestiture of $10.7 million. Organic cost of sales increased primarily due to the increase sales volume noted above as well as approximately $24.9 million in prior period reductions in acquired contract reserves. These increases were partially offset by the increase in recognition of grant benefits under the AMJP agreement with the DOT of approximately $2.6 million and prior period increases in inventory reserves. Organic gross margin for the nine months ended December 31, 2022, was 29.5% compared with 32.0% for the nine months ended December 31, 2021. Organic gross margin decreased primarily as a result of changes in sales mix and the prior period acquired contract reserve reductions, partially offset by the increase in recognition of grant benefits under the AMJP agreement, as well as increased margin benefits on the current year intellectual property sale.
Organic operating income increased by $4.8 million, or 4.2%. The Staverton, United Kingdom, divestiture did not have a significant impact on operating income. Organic operating income increased primarily due to the increased gross profit described above as well as approximately $3.8 million in decreased administrative human capital related costs. The increase in Adjusted EBITDAP year over year is due to the same factors that increased operating income.
Operating income as a percentage of sales and Adjusted EBITDAP as a percentage of segment sales both decreased due to the factors described above.
34
Organic net sales increased by $25.4 million, or 27.0%, offset by declines from approximately $17.2 million in consideration payable to a customer recognized in the three months ended June 30, 2022, related to the divestiture of our Stuart manufacturing operations, along with the sales decreases from recent divestitures of $145.3 million and sunsetting programs (i.e., 747-8 and G280) of $21.0 million. Organic net sales increased primarily due to increased OEM volume on the 737 partially offset by decreased volume on certain commercial widebody programs. Net sales for the nine months ended December 31, 2022 included $12.6 million in nonrecurring revenue compared to $17.1 million in nonrecurring revenue for the nine months ended December 31, 2021.
Organic cost of sales increased by $4.5 million, or 5.0%, offset by declines from the costs of sales of recent divestitures of $114.9 million and sunsetting programs of $22.4 million. The increase in organic cost of sales is due to increase in sales volume described above. Organic gross margin for the nine months ended December 31, 2022, was 20.3% compared with 3.6% for the nine months ended December 31, 2021, primarily from a reduction in losses from our Spokane, Washington, manufacturing operations. The gross margin included net favorable cumulative catch-up adjustments of $19.2 million. The net favorable cumulative catch-up adjustments included gross favorable adjustments of $24.0 million and gross unfavorable adjustments of $4.8 million. The net favorable cumulative catch-up adjustment for the nine months ended December 31, 2021, was $12.9 million.
Organic operating loss decreased by $36.8 million, or 131.3%, primarily due to the increased gross margins, decreased restructuring costs of $9.3 million related to closure of a facility and decreased administrative human capital related costs of $2.8 million. The decreased organic operating loss was offset by decreased operating income from divestitures and sunsetting programs by approximately $22.3 million and $17.2 million from the consideration payable to a customer. The increase in Adjusted EBITDAP year over year is driven by the same factors that affected operating income except for the current year reduction in revenue from consideration payable to a customer, as well as approximately $9.6 million in reduced depreciation expense. Both of these factors affected operating income but are excluded from Adjusted EBITDAP.
Operating income as a percentage of segment sales decreased primarily from the reduction in revenue from consideration payable to a customer. The increase in Adjusted EBITDAP margin is driven by the same factors except for the reduction in revenue from consideration payable to a customer and the decreased depreciation expense, which are excluded from Adjusted EBITDAP.
Liquidity and Capital Resources
Operating Cash Flows
Our working capital needs are generally funded through our current cash and cash equivalents, cash flows from operations, and the availability of proceeds from the Securitization Facility. During the nine months ended December 31, 2022, we had a net cash outflow of $112.3 million from operating activities compared with a net cash outflow of $170.0 million for the nine months ended December 31, 2021, an improvement of $57.7 million, driven in large part by the resolution of long standing customer advances, which were transferred in the sale of our Stuart manufacturing operations and subsequently settled by the buyer in July 2022. Cash flows were primarily driven by timing of payables as well as increases in inventory as a result of anticipated increasing demand and certain supply chain constraints that we expect will largely recover over the fourth quarter of fiscal 2023. Cash flows from operations improved in the third fiscal quarter, and we expect continued improvement in the remainder of fiscal 2023. Interest payments were approximately $89.2 million for the nine months ended December 31, 2022, as compared with $110.5 million for the nine months ended December 31, 2021. The decrease in interest payments is primarily the result of decreased interest expense described above as well as the timing of the final interest payments on the Company's 5.250% Senior Notes due June 1, 2022, which were fully redeemed in the first quarter of fiscal 2022.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law. The CARES Act provided for, among other things, deferred payment of the employer portion of social security taxes through the end of 2020, with 50% of the deferred amount due December 31, 2021, and the remaining 50% due December 31, 2022. Of the approximately $17.8 million of these deferred payments, we paid approximately $8.9 million in December 2021 and the remaining $8.9 million was repaid in December 2022 in accordance with the provisions of the CARES Act described above. These amounts are fully settled as of December 31, 2022.
As disclosed in Note 2, in November 2021 the Company entered into an agreement with the DOT under the AMJP. We received total proceeds under this program of $19.4 million, of which approximately $8.8 million was received in the three months ended
35
June 30, 2022; compared to $10.6 million received in the nine months ended December 31, 2021. These cash receipts are classified within cash from operations. Refer to Note 2 for further discussion.
Investing Cash Flows
Cash flows used in investing activities for the nine months ended December 31, 2022, increased $199.5 million from the nine months ended December 31, 2021. Cash flows used in investing activities for the nine months ended December 31, 2022, included payments related to the sales of assets and businesses of $6.2 million as a result of the Stuart manufacturing operations and settlement of working capital true-ups on prior divestitures, as described in Note 3. We also used approximately $12.3 million for capital expenditures. Cash flows provided by investing activities for the nine months ended December 31, 2021, included cash from the sale of assets and businesses of $220.6 million with additional investing outflows from capital expenditures of $15.8 million and the purchase of a facility in Rayong, Thailand that was included in the related divestiture transaction. We currently expect full year capital expenditures in fiscal 2023 to be in the range of $25.0 million, of which approximately $22.0 million pertains to our core Systems & Support operating segment. The majority of our fiscal 2023 capital expenditures are capital investments designed to improve our manufacturing efficiency and expand our capabilities.
Financing Cash Flows
Cash flows provided by financing activities for the nine months ended December 31, 2022, were $8.3 million, compared with cash flows used in financing activities for the nine months ended December 31, 2021, of $391.6 million, the latter being principally related to debt redemption. Current period financing cash flows pertain primarily to a draw on our securitization facility of $35.0 million, redemption of approximately $19.3 million of the First Lien Notes, borrowings and payments under finance leases, and the repurchase of common stock to satisfy employee tax withholding obligations resulting from equity compensation. As of December 31, 2022, we had $116.4 million of cash on hand and $10.9 million was available under our Securitization Facility after giving effect to approximately $21.3 million in outstanding letters of credit, all of which were accruing interest at 0.125% per annum, and the current outstanding balance.
As disclosed in Note 12, the exit of our composites manufacturing operations in Spokane, Washington may trigger a multiemployer pension plan withdrawal obligation that, if incurred, would likely be satisfied through annual payments over a period of at least ten years.
As a result of stock market volatility, the performance of our defined benefit pension plan assets, and the timing of our annual Employee Retirement Income Security Act of 1974 ("ERISA") measurement date for our domestic defined benefit pension plan, we do not expect any minimum required contribution to be made in fiscal 2023, but we do currently expect an increase to our minimum required contributions through fiscal 2027 as compared to what we disclosed in our Form 10-K for the year ended March 31, 2022, filed on May 23, 2022.
The Senior Notes are our senior obligations and rank equally in right of payment with all of our other existing and future senior indebtedness and senior in right of payment to all of our existing and future subordinated indebtedness.
The First Lien Notes are (a) effectively senior to all existing and future second lien obligations (including the 2024 Notes) and all existing and future unsecured indebtedness of the Company and the Guarantor Subsidiaries, but only to the extent of the value of the Collateral (as defined below), and after giving effect to any permitted additional first lien secured obligations and other permitted liens of senior or equal priority; (b) secured by the Collateral on a pari passu basis with any future permitted additional first lien secured obligations, subject to a collateral trust agreement; (c) effectively subordinated to any existing and future obligations of the Company and the Guarantor Subsidiaries that are secured by assets that do not constitute the Collateral, in each case, to the extent of the value of the assets securing such obligations; and (d) structurally subordinated to all existing and future indebtedness and other liabilities of the Company’s existing and future subsidiaries that do not guarantee the First Lien Notes, including the Securitization Facility.
The 2024 Notes are (a) effectively subordinated to all obligations of the Company and its subsidiary guarantors that are either (1) secured by a lien on the Collateral (as defined below) that is senior or prior to the second-priority liens securing the 2024 Notes, including the first-priority liens securing the First Lien Notes and certain cash management and hedging obligations, or (2) secured by assets that do not constitute the Collateral, in each case to the extent of the value of the assets securing such obligations; (b) effectively senior to all existing and future unsecured debt of the Company and its subsidiary guarantors, but only to the extent of the value of the Collateral (after giving effect to any senior liens on the Collateral); and (c) are structurally subordinated in right of payment to all indebtedness and other liabilities of the Company’s existing and future subsidiaries that do not guarantee the 2024 Notes, including the Receivables Securitization Facility.
The 2025 Notes are effectively subordinated to all obligations of the Company and its subsidiary guarantors that are (A) secured by a lien on the Collateral (including the First Lien Notes and the 2024 Notes) and certain cash management and hedging obligations, or (B) secured by assets that do not constitute the Collateral, in each case to the extent of the value of the assets securing such obligations.
36
The Senior Notes are guaranteed on a full, joint and several basis certain of the Company’s domestic restricted subsidiaries (the “Guarantor Subsidiaries”). Currently, our only consolidated subsidiaries that are not guarantors of the Senior Notes (the "Non-Guarantor Subsidiaries") are: (i) the receivables securitization special purpose entity, and (ii) the foreign operating subsidiaries. The First Lien Notes and the related guarantees are secured by first-priority liens on substantially all of our assets and our subsidiary guarantors, whether now owned or hereafter acquired (the “Collateral”). The 2024 Notes, and the related guarantees are secured, subject to permitted liens, by second-priority liens on the Collateral. The Senior Notes and the related guarantees are not secured by the assets of Non-Guarantor Subsidiaries. Some of our assets are excluded from the Collateral, including certain real property assets.
Pursuant to the documentation governing the Senior Notes, we may redeem some or all of the Senior Notes prior to their stated maturities, subject to certain limitations set forth in the indenture governing the applicable Senior Notes and, in certain cases, subject to significant prepayment premiums. We are obligated to offer to repurchase the Senior Notes at specified prices as a result of certain change-of-control events and a sale of all or substantially all of our assets. These restrictions and prohibitions are subject to certain qualifications and exceptions.
The indentures governing the Senior Notes, as well as Securitization Facility, contain covenants and restrictions that, among other things, limit our ability and the ability of any of the Guarantor Subsidiaries to (i) grant liens on our assets; (ii) make dividend payments, other distributions or other restricted payments; (iii) incur restrictions on the ability of the Guarantor Subsidiaries to pay dividends or make other payments or investments; (iv) enter into sale and leaseback transactions; (v) merge, consolidate, transfer or dispose of substantially all of their assets; (vi) incur additional indebtedness; (vii) use the proceeds from sales of assets, including capital stock of restricted subsidiaries (in the case of the Senior Notes); and (viii) enter into transactions with affiliates.
We are currently in compliance with all covenants under our debt documents and expect to remain in compliance for the foreseeable future.
For further information on our long-term debt, see Note 6.
The following tables present summarized financial information of the Company and the Guarantor Subsidiaries on a combined basis. The combined summarized financial information eliminates intercompany balances and transactions among the Company and the Guarantor Subsidiaries and equity in earnings and investments in any Guarantor Subsidiaries or Non-Guarantor Subsidiaries. The summarized financial information is provided in accordance with the reporting requirements of Rule 13-01 under SEC Regulation S-X for the issuer and Guarantor Subsidiaries.
Parent and Guarantor Summarized Financial Information
Summarized Balance Sheet
in thousands
Assets
Due from non-guarantor subsidiaries
8,292
1,034
Current assets
573,725
705,662
Noncurrent assets
644,961
661,160
Noncurrent receivable from non-guarantor subsidiaries
55,748
92,865
Liabilities
Due to non-guarantor subsidiaries
26,690
15,079
Current liabilities
332,898
562,731
Noncurrent liabilities
1,872,383
1,938,864
Nine Months Ended
Summarized Statement of Operations
Net sales to non-guarantor subsidiaries
1,718
Net sales to unrelated parties
898,814
Gross profit
235,802
Income from continuing operations before income taxes
101,496
100,506
Critical Accounting Policies
Our critical accounting policies are discussed in Management's Discussion and Analysis of Financial Condition and Results of Operations and notes accompanying the consolidated financial statements that appear in the Annual Report on Form 10-K for the
37
fiscal year ended March 31, 2022. Except as otherwise disclosed in the condensed consolidated financial statements and accompanying notes included in this report, there were no material changes subsequent to the filing of the Annual Report on Form 10-K for the fiscal year ended March 31, 2022, in our critical accounting policies or in the assumptions or estimates used to prepare the financial information appearing in this report.
Forward-Looking Statements
This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 relating to our future operations and prospects, including statements that are based on current projections and expectations about the markets in which we operate, and our beliefs concerning future performance and capital requirements based upon current available information. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “expect,” “anticipate,” “believe,” “potential,” "plan," "estimate," and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations. For example, there can be no assurance that additional capital will not be required or that additional capital, if required, will be available on reasonable terms, if at all, at such times and in such amounts as may be needed by us. In addition to these factors, among other factors that could cause actual results to differ materially are uncertainties relating to our ability to execute on our restructuring plans, the integration of acquired businesses, divestitures of our business, general economic conditions affecting our business, dependence of certain of our businesses on certain key customers as well as competitive factors relating to the aviation industry. For a more detailed discussion of these and other factors affecting us, see the risk factors described in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022, filed with the SEC on May 23, 2022, and in our quarterly reports on Form 10-Q.
38
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
For information regarding our exposure to certain market risks, see “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022. There has been no material change in this information during the period covered by this report.
Item 4. Controls and Procedures.
(a) Evaluation of disclosure controls and procedures.
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports pursuant to the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
As of December 31, 2022, we completed an evaluation, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of December 31, 2022.
(b) Changes in internal control over financial reporting.
There were no changes that occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.
Item 1. Legal Proceedings.
Not applicable.
Item 1A. Risk Factors.
There have been no material changes in our risk factors from those disclosed in Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Repurchases of Stock
Information about our repurchases during the three months ended September 30, 2022, of our common stock that is registered pursuant to Section 12 of the Exchange Act is disclosed in the table below.
Period
Total Number of Shares Purchased (1)
Average Price Paid Per Share (2)
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Maximum number of shares that may yet be purchased under existing programs
October 1, 2022 - October 31, 2022
2,277,789
November 1, 2022 - November 30, 2022
December 1, 2022 - December 30, 2022
(1) Represents shares surrendered to the Company due to restricted share forfeitures or to satisfy tax withholding obligations in connection with employees’ share-based compensation awards.
(2) Excludes shares acquired at no cost as a result of restricted share forfeitures.
Item 3. Defaults Upon Senior Securities.
Item 4. Mine Safety Disclosures.
Item 5. Other Information.
Item 6. Exhibits.
Exhibit 10.1
Warrant Agreement, dated as of December 19, 2022, between the Company, Computershare Inc., a Delaware corporation, and its affiliate Computershare Trust Company, N.A., as Warrant Agent. (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on December 20, 2022)
Exhibit 22.1
List of Subsidiary Guarantors and Issuers of Guaranteed Securities.
Exhibit 31.1
Certification by the Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a).
Exhibit 31.2
Certification by the Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a).
Exhibit 32.1
Certification of Chief Executive Officer and Chief Financial Officer Furnished Pursuant to 18 U.S.C. Section 1350 Adopted Pursuant to Section 906 Sarbanes-Oxley Act of 2002.
Exhibit 101
The following financial information from Triumph Group, Inc.’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2022, formatted in iXBRL: (i) Condensed Consolidated Balance Sheets as of December 31, 2022 and March 31, 2022; (ii) Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2022 and 2021; (iii) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended December 31, 2022 and 2021; (iv) Condensed Consolidated Statements of Stockholders' Deficit for the three and nine months ended December 31, 2022 and 2021; (v) Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2022 and 2021; and (vi) Notes to Condensed Consolidated Financial Statements.
Exhibit 104
Cover Page Interactive Data File, formatted as Inline XBRL and contained in Exhibit 101.
41
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
(Registrant)
President and Chief Executive Officer
February 1, 2023
/s/ Daniel J. Crowley
(Principal Executive Officer)
Daniel J. Crowley
Senior Vice President and Chief Financial Officer
/s/ James F. McCabe, Jr.
(Principal Financial Officer)
James F. McCabe, Jr.
Vice President, Controller
/s/ Kai W. Kasiguran
(Principal Accounting Officer)
Kai W. Kasiguran